Home HOME Neoplasma 2022 Neoplasma Vol.69, No.2, p.404–411, 2022

Journal info


6 times a year.
Founded: 1954
ISSN 0028-2685
ISSN 1338-4317 (online)

Published in English

Editorial Info
Abstracted and Indexed
Submission Guidelines

Select Journal







Webshop Cart

Your Cart is currently empty.

Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

Neoplasma Vol.69, No.2, p.404–411, 2022

Title: Correlation between radiological and biological features and clinical outcomes in early prostate cancer: an exploratory subgroup analysis
Author: Giulia Corrao, Giulia Marvaso, Mattia Zaffaroni, Stefania Volpe, Matteo Augugliaro, Cristiana Iuliana Fodor, Dario Zerini, Andrea Vingiani, Francesco Alessandro Mistretta, Stefano Luzzago, Sarah Alessi, Paola Pricolo, Gennaro Musi, Ottavio De Cobelli, Giuseppe Renne, Marco Manzoni, Giuseppe Petralia, Roberto Orecchia, Barbara Alicja Jereczek-Fossa

Abstract: PTEN deletion and Ki-67 expression are two of the most promising biomarkers in prostate cancer (PCa). In the same manner, multiparametric magnetic resonance imaging (mp-MRI) guided core biopsy is a powerful tool for PCa detection and staging. The aim of the study is to assess whether a correlation can be identified between the pathological stage defined by an mp-MRI-guided core-biopsy and Ki-67 expression and PTEN deletion. Such correlation might be useful for staging and treatment personalization in PCa. This investigation was conducted in the context of phase II clinical study "Short-term radiotherapy for early prostate cancer with a concomitant boost to the dominant lesion" (AIRC IG-13218), ClinicalTrials.gov identifier: NCT01913717. Nineteen patients underwent a further in-bore MRI-targeted core biopsy (MRI-TBx) on the dominant intraprostatic lesion (DIL); on this basis, an additional Gleason Score (GS) was determined. PTEN loss and Ki-67 expression on these samples were analyzed and correlated with both risk categories modifications and oncological outcomes (overall survival, biochemical and clinical relapse). GS was upgraded in 5 cases, with 4 patients re-classified as intermediate-risk and 1 patient as high-risk. The latter experienced a clinical local relapse. No correlations between up/down-staging, PTEN deletion, and Ki-67 expression were observed in this cohort.
Further investigations are needed towards the identification of a pattern in the tumor aggressiveness-response in PCa treated with ultra-hypofractionated radiotherapy. Moreover, a possible relationship between biomarker analysis and imaging textural features could be explored.

Keywords: PTEN; Ki-67; biomarkers; early prostate cancer; mp-MRI
Published online: 11-Jan-2022
Year: 2022, Volume: 69, Issue: 2 Page From: 404, Page To: 411
doi:10.4149/neo_2021_210622N828
Price: 16.80 €






© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.